Picture of Bright Green logo

BGXX Bright Green Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+17.62%
3m-0.06%
6m-26.6%
1yr-76.22%
Volume Change (%)
10d/3m-65.67%
Price vs... (%)
52w High-73.54%
50d MA+17.35%
200d MA-0.67%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-63.37%
Return on Equity-100.24%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Bright Green EPS forecast chart

Profile Summary

Bright Green Corporation is a producer and manufacturer of plant-based drugs and active pharmaceutical ingredients (APIs). The Company specializes in the research, production, distribution, and advancement of plant-based drugs and APIs, including psilocybin, psilocyn, peyote, and opium poppy. It plans to focus on the development of cannabis strains and sales of cannabis and hemp products with high contents of cannabinol (CBN) and cannabigerol (CBG). It also plans to cultivate cannabis and focus on the production of dried flowers, and oils and marijuana extracts. In addition to cannabis, it also has a separate area for controlled substance cactus cultivation, and a separate controlled area for mushroom propagation. It is in the process of completing construction of the 22-acre existing greenhouse to comply with the requirements for Schedule I and Schedule II plant-based drugs. It also plans to construct two new 57-acre greenhouses, one each on the Candelaria property and Azuz property.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    April 16th, 2019
    Public Since
    May 17th, 2022
    No. of Shareholders
    100
    No. of Employees
    5
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    190,166,318

    BGXX Share Price Performance

    Similar to BGXX

    Picture of 60 Degrees Pharmaceuticals logo

    60 Degrees Pharmaceuticals

    us flag iconNASDAQ Capital Market

    Picture of Aadi Bioscience logo

    Aadi Bioscience

    us flag iconNASDAQ Capital Market

    Picture of Acasti Pharma logo

    Acasti Pharma

    us flag iconNASDAQ Capital Market

    Picture of Agriforce Growing Systems logo

    Agriforce Growing Systems

    us flag iconNASDAQ Capital Market

    Picture of Aptorum logo

    Aptorum

    us flag iconNASDAQ Capital Market

    FAQ